Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| United States | $385M | 39.2% |
| Japan | $132.7M | 13.5% |
| Switzerland | $99.9M | 10.2% |
| Netherlands | $39.5M | 4.0% |
| Spain | $36.9M | 3.8% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| United States | $5.3M | 62.5% |
| Japan | $1.1M | 12.8% |
| South Korea | $940K | 11.1% |
| Russia | $325.8K | 3.8% |
| Colombia | $320.3K | 3.8% |
| Year | Export value |
|---|---|
| 2021 | $186.1M |
| 2022 | $219M |
| 2023 | $171.6M |
| 2024 | $164.3M |
| 2025 | $145.9M |
| 2026 | $94.2M |
Public data shows up to 5 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.
HS 30019090 is also written 3001.90.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Preparations of human or animal origin intended for therapeutic or prophylactic uses, capturing those substances not elsewhere specified or classified as heparin. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Substances of human or animal origin, for therapeutic uses, nes (HS 30019090) Export Data." https://chinadata.live/china-trade/hs8/30019090/
HS 30019090 is also written 3001.90.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Preparations of human or animal origin intended for therapeutic or prophylactic uses, capturing those substances not elsewhere specified or classified as heparin. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Substances of human or animal origin, for therapeutic uses, nes (HS 30019090) Export Data." https://chinadata.live/china-trade/hs8/30019090/
China exported $142M of substances of human or animal origin, for therapeutic uses, nes in the twelve months to August 2026, averaging $11.9M per month, based on official China customs statistics (HS 30019090).
Preparations of human or animal origin intended for therapeutic or prophylactic uses, capturing those substances not elsewhere specified or classified as heparin.
United States, Japan and Switzerland together account for 63% of the published total, out of 42 trading partners on record.
Annual exports declined by 22% between 2021 and 2025, from $186M to $146M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.